We are exploring how different doses of an intravenous medication, sodium thiosulfate, may help improve blood flow in people with Raynaud’s phenomenon. The study will also look at the safety and how the body reacts to the treatment.
Health conditions and diseases that the clinical trial is designed to study and treat.
Raynaud's phenomenon is a condition that causes some areas of your body, usually your fingers and toes, to feel numb and cold in response to stress or cold temperatures. This happens due to smaller arteries that supply blood to your skin constricting excessively.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.